Last reviewed · How we verify
NCT01485913
A Randomized Trial of an Intensive Education Intervention Using a Network of Involved Diabetic Patients (Peer Educators) to Improve Glycemic Control of Type 2 Diabetic Patients
NA trial testing intensive education intervention using a network of involved diabetic patients (peer educators) in Diabetes in 151 participants. Completed in 30 June 2013.
31 December 2012
Quick facts
| Lead sponsor | Sante Diabete Mali |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 151 |
| Start date | 1 July 2011 |
| Primary completion | 31 December 2012 |
| Estimated completion | 30 June 2013 |
| Sites | 1 location across Mali |
Drugs / interventions tested
- intensive education intervention using a network of involved diabetic patients (peer educators)
Conditions studied
- Diabetes — all drugs for Diabetes →
Sponsor
Sante Diabete Mali
Who can join
Adults 30 to 80, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project will test the implementation of a specific methodology for education of type 2 diabetic patients that will be set up using patients involved (peer educators) and 3 guides developed specifically for the therapeutic education of type 2 diabetic patients. This project will take place in 1 sites in mali : the capital Bamako. 75 diabetic patients will be subjected to intervention with this methodology and 75 other diabetic patients will be the control group. At various stages of the project, the investigators will analyze the impact on biological, anthropological constants, etc ... of the group undergoing the intervention compared to the control group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Structured peer-led diabetes self-management and support in a low-income country: The ST2EP randomised controlled trial in Mali.
Debussche X, Besançon S, Balcou-Debussche M, Ferdynus C, et al · · 2018 · cited 81× · PMID 29357380 · DOI 10.1371/journal.pone.0191262
Verify or expand the search:
- PubMed search for NCT01485913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01485913 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sante Diabete Mali
- Last refreshed: 28 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01485913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing